Off-pump pulmonary valve replacement with the new Shelhigh Injectable Stented Pulmonic Valve

Abstract

Listen

Translate article

ignificant pulmonary regurgitation (PR) is common after surgical or percutaneous treatment of pulmonary stenosis and tetralogy of Fallot (TOF) and leads to significant late morbidity and mortality. Optimal timing of pulmonary alve replacement (PVR) and procedures minimizing surgical trauma re therefore important. The new Shelhigh Injectable Stented Pulonic Valve NR4000-PA MIS (Shelhigh Inc, Union, NJ) offers the ossibility of PVR without cardiopulmonary bypass (CPB). Here we eport our early experience with the first clinical use of this new evice.